Results 91 to 100 of about 651,564 (257)

Two‐year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER‐Medicare analysis

Head and Neck, 2018
The aim of the study was to examine prevalence of dysphagia at the population level in head and neck cancer (HNC) survivors.
K. Hutcheson, Z. Nurgalieva, Hui Zhao, G. Gunn, S. Giordano, M. Bhayani, J. Lewin, C. Lewis   +7 more
semanticscholar   +1 more source

ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer

Oxidative Medicine and Cellular Longevity, 2020
Head and neck cancer is a highly genetic and metabolic heterogeneous collection of malignancies of the lip, oral cavity, salivary glands, pharynx, esophagus, paranasal sinuses, and larynx with five-year survival rates ranging from 12% to 93%.
Gan Huang, S. Pan
semanticscholar   +1 more source

Stage T4B head and neck cancer survival outcome comparisons based on treatment modality: is surgery a viable treatment option? [PDF]

, 2016
IMPORTANCE: Advanced stage head and neck cancers are often deemed unresectable due to the aggressive nature of the cancer. In evaluating survival patterns of patients with stage IVb tumors, it is valuable to determine whether patients who undergo ...
Kidwai, Neiha
core   +1 more source

Updated Clinical Considerations for Dental Implant Therapy in Irradiated Head and Neck Cancer Patients [PDF]

, 2013
An increasing number of reports indicate successful use of dental implants (DI) during oral rehabilitation for head and neck cancer patients undergoing tumor surgery and radiation therapy.
Chan, Hsun‐liang, MacEachern, Mark, Oh, Tae‐ju, Tanaka, Takako Imai, Tindle, David Ira   +4 more
core   +1 more source

Swallowing Disorders After Treatment for Head and Neck Cancer

Radiology and Oncology, 2019
Background Dysphagia is a common consequence of treatment for head and neck cancer (HNC). The purpose of the study was to evaluate the prevalence of dysphagia in a group of patients treated for HNC in Slovenia, and to identify factors contributing to the
Martina Pezdirec, P. Strojan, I. H. Boltežar   +2 more
semanticscholar   +1 more source

mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity

Laryngoscope Investigative Otolaryngology, 2020
Background Head and neck squamous cell carcinoma (HNSCC) has been rising in incidence primarily related to HPV‐associated oropharyngeal cancers. Novel molecular therapeutics are evolving with the mTOR pathway as a new target.
Jaimin Patel, Shaun A. Nguyen, Besim Ogretmen, Jorge S. Gutkind, Cherie‐Ann Nathan, Terry Day   +5 more
doaj   +1 more source

Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource:head and neck 5000 [PDF]

, 2014
BACKGROUND: Head and neck cancer is an important cause of ill health. Survival appears to be improving but the reasons for this are unclear. They could include evolving aetiology, modifications in care, improvements in treatment or changes in lifestyle ...
Abdelkader, Maged, Ahmed, Imtiaz, Allmark, Christine, Anari, Shahram, Andrade, Gerard, Baldwin, Andrew, Balfour, Alistair, Barnes, Debi, Beaumont-Jewell, Dawn, Benson, Richard, Berry, Sandeep, Bisase, Brian, Brammer, Caroline, Carr, Ruth, Casasola, Richard, Christian, Judith, Coatesworth, Andrew, Cogill, Geoffrey, Cole, Naomi, Conway, David, Dallas, Nicola, Davies, Joe, Doyle, Margret, Dyker, Karen, Dyson, P, England, James, Evans, Andrew, Evans, Mererid, Fisher, Sheila, Foran, Bernie, Forster, Martin, Fresco, Lydia, Gahir, Daljit, Gollins, Simon, Goodchild, Kate, Gunasekaran, Sinnappa P, Hall, Charles, Hamid, Abdel, Hari, Churunal, Hollingworth, Will, Homer, Jarrod, Hurley, Katrina, Hwang, David, Hyde, Nicholas, Jankowska, Petra, Jeffreys, Mona, Kim, Dae, King, Emma, Lamont, Alan, Leary, Sam, Lees, Laura, Lester, Jim, Lester, Shane, Loo, H W, Lowe, Rachel, Mano, Joseph, McAllister, Ken, McCaul, James, Mehanna, Hisham, Moss, Laura, Moule, Russell, Ness, Andrew Robert, Nutting, Chris, Nutting, Christopher, O'Hara, James, Palaniappan, Nachi, Paleri, Vinidh, Penfold, Chris, Persson, Martin, Peters, Tim J, Pring, Miranda, Repanos, Costas, Richards, Stuart, Ring, Susan, Rogers, Simon, Roques, Tom, Rowell, Nick, Roy, Amy, Scrase, Christopher, Sen, Mehmet, Sheehan, Tom, Simcock, Richard, Siva, Muthu, Stewart, Simon, Tatla, Taran, Thiruchelvam, J K, Thomas, Steve, Tierney, Paul, Toms, Stu, Tyler, Jayne, Wagstaff, Lynda, Waldron, John, Waylen, Andrea, Wight, Richard, Winter, Stuart, Wood, Christine, Wood, Katie, Worthington, Helen   +97 more
core   +5 more sources

Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors

JAMA Otolaryngology - Head and Neck Surgery, 2019
Importance Head and neck cancer (HNC) is more common among socioeconomically disenfranchised individuals, making financial burden particularly relevant. Objective To assess the financial burdens of HNC compared with other cancers.
S. Massa, N. Osazuwa-Peters, Eric Adjei Boakye, Ronald J. Walker, Gregory M. Ward   +4 more
semanticscholar   +1 more source

Evaluating the manubrium sterni as a site for bone implantation: a 3D radiological feasibility study

European Radiology Experimental
Background To increase the number of patients who can speak hands-free after total laryngectomy, we aim to assess the viability of the manubrium sterni bone (MSB) for bone implantation.
Max Johannes Dullaart, Maarten Jan Antony van Alphen, Annelieke Boudina Schoen, Margje Bertine Buitenhuis, Loes Margaretha Marie Braun, Menno Krap, Michiel Wilhelmus Maria van den Brekel, Luc Hendricus Elizabeth Karssemakers, Richard Dirven   +8 more
doaj   +1 more source

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Nature Reviews. Cancer, 2022
A. Ruffin, Housaiyin Li, L. Vujanović, D. Zandberg, R. Ferris, T. Bruno   +5 more
semanticscholar   +1 more source